Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keywan Mortezaee

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Life Sciences|May 18, 2021
Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectivesKeywan Mortezaee
Life Sciences|March 12, 2020
CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasisKeywan Mortezaee
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2023
HHLA2 immune-regulatory roles in cancerKeywan Mortezaee
Life Sciences|December 10, 2019
Hypoxia induces core-to-edge transition of progressive tumoral cells: A critical review on differential yet corroborative roles for HIF-1α and HIF-2αKeywan Mortezaee
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 17, 2023
B7-H3 immunoregulatory roles in cancerKeywan Mortezaee
Human Cell|August 25, 2025
Regulatory T cells in cancer anti-PD-(L)1 therapyKeywan Mortezaee
International Immunopharmacology|April 7, 2023
B7x in cancer immunity and immunotherapyKeywan Mortezaee
Immunology|December 28, 2025
Regulatory T Cell Metabolism in CancerKeywan Mortezaee
Pathology, Research and Practice|April 30, 2025
EZH2 regulatory roles in cancer immunity and immunotherapyKeywan Mortezaee
Cell Biology International|November 25, 2020
Redox tolerance and metabolic reprogramming in solid tumorsKeywan Mortezaee
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Life Sciences|May 18, 2021
Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectivesKeywan Mortezaee
Life Sciences|March 12, 2020
CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasisKeywan Mortezaee
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2023
HHLA2 immune-regulatory roles in cancerKeywan Mortezaee
Life Sciences|December 10, 2019
Hypoxia induces core-to-edge transition of progressive tumoral cells: A critical review on differential yet corroborative roles for HIF-1α and HIF-2αKeywan Mortezaee
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 17, 2023
B7-H3 immunoregulatory roles in cancerKeywan Mortezaee
Human Cell|August 25, 2025
Regulatory T cells in cancer anti-PD-(L)1 therapyKeywan Mortezaee
International Immunopharmacology|April 7, 2023
B7x in cancer immunity and immunotherapyKeywan Mortezaee
Immunology|December 28, 2025
Regulatory T Cell Metabolism in CancerKeywan Mortezaee
Pathology, Research and Practice|April 30, 2025
EZH2 regulatory roles in cancer immunity and immunotherapyKeywan Mortezaee
Cell Biology International|November 25, 2020
Redox tolerance and metabolic reprogramming in solid tumorsKeywan Mortezaee
Pageof 15